FRIEDMAN PAUL A Insider Trading
Get the latest insider transactions of FRIEDMAN PAUL A. FRIEDMAN PAUL A is Chief Executive Officer in INCYTE CORP ($INCY) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and Chief Executive Officer in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in Cerulean Pharma Inc. ($CERU) and Director in Verastem, Inc. ($VSTM) and Director in Prelude Therapeutics Inc ($PRLD). Discover the current value of FRIEDMAN PAUL A shares.
Address: 3160 PORTER DRIVE PALO ALTO 94304CA
FRIEDMAN PAUL A is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
INCY | INCYTE CORP | Director, Chief Executive Officer | 256,813 | 30,350,160.34 |
VSTM | Verastem, Inc. | Director | 0 | 0.00 |
DARE | Dare Bioscience, Inc. | Director | 18,819 | 21,830.04 |
SNTA | MADRIGAL PHARMACEUTICALS, INC. | Chief Executive Officer, Director | 161,128 | 0.00 |
ALXN | ALEXION PHARMACEUTICALS, INC. | Director | 10,345 | 1,321,263.40 |
PRLD | Prelude Therapeutics Inc | Director | 347,522 |
Insider Trading Transactions of FRIEDMAN PAUL A
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | PRLD | Prelude Therapeutics Inc | FRIEDMAN PAUL A | Director | Option Exercise | 31.02 | 23,344 | 724,131 | 23,344 |
Feb 23 2021 | SNTA | MADRIGAL PHARMACEUTICALS, ... | FRIEDMAN PAUL A | Chief Executive Offic ... | Option Exercise | 119.49 | 50,000 | 5,974,500 | 50,000 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | FRIEDMAN PAUL A | Director | Buy | 0.00 | 295,794 | 0 | 347,522 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | FRIEDMAN PAUL A | Director | Buy | 0.00 | 152,576 | 0 | 500,098 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | FRIEDMAN PAUL A | Director | Option Exercise | 0.00 | 76,288 | 0 | 152,576 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | FRIEDMAN PAUL A | Director | Option Exercise | 0.00 | 295,794 | 0 | 0 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | FRIEDMAN PAUL A | Director | Option Exercise | 0.00 | 152,576 | 0 | 0 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | FRIEDMAN PAUL A | Director | Buy | 0.00 | 295,794 | 0 | 347,522 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | FRIEDMAN PAUL A | Director | Buy | 0.00 | 152,576 | 0 | 500,098 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | FRIEDMAN PAUL A | Director | Option Exercise | 0.00 | 76,288 | 0 | 152,576 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | FRIEDMAN PAUL A | Director | Option Exercise | 0.00 | 295,794 | 0 | 0 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | FRIEDMAN PAUL A | Director | Option Exercise | 0.00 | 152,576 | 0 | 0 |
May 28 2020 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | 0.00 | 1,282 | 0 | 256,813 |
May 28 2020 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 98.68 | 10,514 | 1,037,522 | 10,514 |
May 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | FRIEDMAN PAUL A | Director | Buy | 0.00 | 3,468 | 0 | 10,345 |
Mar 05 2020 | SNTA | MADRIGAL PHARMACEUTICALS, ... | FRIEDMAN PAUL A | Chief Executive Offic ... | Option Exercise | 91.79 | 50,000 | 4,589,500 | 50,000 |
Aug 06 2019 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | 18.32 | 22,066 | 404,249 | 277,597 |
Aug 06 2019 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 84.41 | 22,066 | 1,862,591 | 255,531 |
Aug 06 2019 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | 18.32 | 77,934 | 1,427,751 | 333,465 |
Aug 06 2019 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 82.20 | 77,934 | 6,406,175 | 255,531 |
Aug 06 2019 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 18.32 | 22,066 | 404,249 | 77,934 |
Aug 06 2019 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 18.32 | 77,934 | 1,427,751 | 0 |
Apr 29 2019 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | 0.00 | 1,520 | 0 | 255,531 |
Apr 29 2019 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 75.03 | 12,472 | 935,774 | 12,472 |
Mar 11 2019 | SNTA | MADRIGAL PHARMACEUTICALS, ... | FRIEDMAN PAUL A | Chief Executive Offic ... | Option Exercise | 127.96 | 50,000 | 6,398,000 | 50,000 |
Nov 23 2018 | SNTA | MADRIGAL PHARMACEUTICALS, ... | FRIEDMAN PAUL A | Chief Executive Offic ... | Buy | 117.88 | 4,000 | 471,520 | 161,128 |
Nov 19 2018 | SNTA | MADRIGAL PHARMACEUTICALS, ... | FRIEDMAN PAUL A | Chief Executive Offic ... | Buy | 124.00 | 4,000 | 496,000 | 157,128 |
Jun 12 2018 | SNTA | MADRIGAL PHARMACEUTICALS, ... | FRIEDMAN PAUL A | Chief Executive Offic ... | Sell | 287.46 | 73,526 | 21,135,784 | 655,540 |
Jun 12 2018 | SNTA | MADRIGAL PHARMACEUTICALS, ... | FRIEDMAN PAUL A | Chief Executive Offic ... | Sell | 287.46 | 73,526 | 21,135,784 | 655,540 |
May 11 2018 | ALXN | ALEXION PHARMACEUTICALS I ... | FRIEDMAN PAUL A | Director | Buy | 0.00 | 2,174 | 0 | 4,151 |
May 03 2018 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 60.85 | 15,000 | 912,750 | 15,000 |
Mar 05 2018 | SNTA | MADRIGAL PHARMACEUTICALS, ... | FRIEDMAN PAUL A | Chief Executive Offic ... | Option Exercise | 124.45 | 50,000 | 6,222,500 | 50,000 |
Nov 30 2017 | ALXN | ALEXION PHARMACEUTICALS I ... | FRIEDMAN PAUL A | Director | Buy | 0.00 | 1,977 | 0 | 1,977 |
Nov 20 2017 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 105.24 | 28,507 | 3,000,077 | 269,011 |
May 31 2017 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 134.38 | 15,000 | 2,015,700 | 15,000 |
Apr 05 2017 | CERU | Cerulean Pharma Inc. | FRIEDMAN PAUL A | Director | Buy | 0.73 | 10,273 | 7,499 | 18,819 |
Mar 20 2017 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | 18.32 | 5,458 | 99,991 | 302,976 |
Mar 20 2017 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | 18.32 | 2,849 | 52,194 | 305,825 |
Mar 20 2017 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 151.45 | 8,307 | 1,258,095 | 297,518 |
Mar 20 2017 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | 18.32 | 41,693 | 763,816 | 339,211 |
Mar 20 2017 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 148.18 | 41,693 | 6,178,069 | 297,518 |
Mar 20 2017 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 18.32 | 5,458 | 99,991 | 0 |
Mar 20 2017 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 18.32 | 2,849 | 52,194 | 141,693 |
Mar 20 2017 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 18.32 | 41,693 | 763,816 | 100,000 |
Mar 06 2017 | SNTA | MADRIGAL PHARMACEUTICALS, ... | FRIEDMAN PAUL A | Chief Executive Offic ... | Option Exercise | 15.80 | 49,600 | 783,680 | 49,600 |
Feb 27 2017 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | 18.32 | 50,000 | 916,000 | 347,518 |
Feb 27 2017 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 120.32 | 50,000 | 6,016,000 | 297,518 |
Feb 27 2017 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 18.32 | 50,000 | 916,000 | 144,542 |
Jan 05 2017 | CERU | Cerulean Pharma Inc. | FRIEDMAN PAUL A | Director | Buy | 0.77 | 4,870 | 3,750 | 8,546 |
Oct 20 2016 | CERU | Cerulean Pharma Inc. | FRIEDMAN PAUL A | Director | Buy | 1.02 | 3,676 | 3,750 | 3,676 |
Jul 26 2016 | SNTA | SYNTA PHARMACEUTICALS COR ... | FRIEDMAN PAUL A | Chief Executive Offic ... | Buy | 0.00 | 146 | 0 | 146 |
Jul 26 2016 | SNTA | SYNTA PHARMACEUTICALS COR ... | FRIEDMAN PAUL A | Chief Executive Offic ... | Buy | 0.00 | 143,557 | 0 | 143,703 |
Jul 26 2016 | SNTA | SYNTA PHARMACEUTICALS COR ... | FRIEDMAN PAUL A | Chief Executive Offic ... | Buy | 0.00 | 729,066 | 0 | 729,066 |
Jul 26 2016 | SNTA | SYNTA PHARMACEUTICALS COR ... | FRIEDMAN PAUL A | Chief Executive Offic ... | Option Exercise | 9.45 | 287,115 | 2,713,237 | 287,115 |
Jun 24 2016 | CERU | Cerulean Pharma Inc. | FRIEDMAN PAUL A | Director | Option Exercise | 2.08 | 20,000 | 41,600 | 20,000 |
Jun 16 2016 | VSTM | Verastem, Inc. | FRIEDMAN PAUL A | Director | Option Exercise | 1.37 | 25,000 | 34,250 | 25,000 |
May 31 2016 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 84.53 | 15,000 | 1,267,950 | 15,000 |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | 17.79 | 100,000 | 1,779,000 | 397,518 |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 112.71 | 7,052 | 794,831 | 390,466 |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 112.53 | 42,948 | 4,832,938 | 347,518 |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 111.37 | 50,000 | 5,568,500 | 297,518 |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | 17.79 | 125,000 | 2,223,750 | 422,518 |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 115.42 | 86,132 | 9,941,355 | 336,386 |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 115.12 | 38,868 | 4,474,484 | 297,518 |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 17.79 | 5,621 | 99,998 | 0 |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 17.79 | 94,379 | 1,679,002 | 125,000 |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 17.79 | 125,000 | 2,223,750 | 0 |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTICALS COR ... | FRIEDMAN PAUL A | Director | Buy | 0.00 | 5,681 | 0 | 5,681 |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTICALS COR ... | FRIEDMAN PAUL A | Director | Buy | 0.00 | 1,136 | 0 | 6,817 |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTICALS COR ... | FRIEDMAN PAUL A | Director | Option Exercise | 2.20 | 20,000 | 44,000 | 20,000 |
Jun 30 2015 | CERU | Cerulean Pharma Inc. | FRIEDMAN PAUL A | Director | Option Exercise | 4.78 | 8,214 | 39,263 | 8,214 |
Jun 30 2015 | CERU | Cerulean Pharma Inc. | FRIEDMAN PAUL A | Director | Option Exercise | 4.78 | 11,000 | 52,580 | 11,000 |
Jun 16 2015 | VSTM | Verastem, Inc. | FRIEDMAN PAUL A | Director | Option Exercise | 7.99 | 19,495 | 155,765 | 19,495 |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | 14.72 | 127,619 | 1,878,552 | 425,137 |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 107.83 | 2,619 | 282,407 | 422,518 |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 107.00 | 50,000 | 5,350,000 | 372,518 |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 107.36 | 2,358 | 253,155 | 370,160 |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 107.00 | 50,000 | 5,350,000 | 320,160 |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 107.15 | 22,642 | 2,426,090 | 297,518 |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | 14.72 | 69,132 | 1,017,623 | 366,650 |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 107.66 | 52,696 | 5,673,251 | 313,954 |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 107.19 | 16,436 | 1,761,775 | 297,518 |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 14.72 | 127,619 | 1,878,552 | 69,132 |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 14.72 | 69,132 | 1,017,623 | 0 |
May 27 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 107.69 | 15,000 | 1,615,350 | 15,000 |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | 14.72 | 8,805 | 129,610 | 306,323 |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | 14.72 | 13,846 | 203,813 | 320,169 |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 108.75 | 8,263 | 898,601 | 311,906 |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 108.92 | 14,388 | 1,567,141 | 297,518 |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | 14.72 | 79,592 | 1,171,594 | 377,110 |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 108.34 | 14,392 | 1,559,229 | 362,718 |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 108.50 | 15,200 | 1,649,200 | 347,518 |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 107.75 | 25,000 | 2,693,750 | 322,518 |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | 107.88 | 25,000 | 2,697,000 | 297,518 |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 14.72 | 8,805 | 129,610 | 0 |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 14.72 | 13,846 | 203,813 | 276,343 |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | 14.72 | 79,592 | 1,171,594 | 196,751 |
Mar 02 2004 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Offic ... | Option Exercise | 8.64 | 30,441 | 263,010 | 30,441 |
Mar 02 2004 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Offic ... | Option Exercise | 8.64 | 1,875 | 16,200 | 32,316 |
Mar 02 2004 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Offic ... | Option Exercise | 8.64 | 144,559 | 1,248,990 | 144,559 |
Mar 02 2004 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Offic ... | Option Exercise | 8.64 | 43,125 | 372,600 | 187,684 |